NIOX Group (NIOX Group) Pre-Tax Income : $5.18 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is NIOX Group Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. NIOX Group's pretax income for the six months ended in Dec. 2023 was $1.52 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $5.18 Mil. NIOX Group's pretax margin was 6.67%.

During the past 13 years, NIOX Group's highest Pretax Margin was 33.55%. The lowest was -581.48%. And the median was -79.77%.

NIOX Group Pre-Tax Income Historical Data

The historical data trend for NIOX Group's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NIOX Group Pre-Tax Income Chart

NIOX Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-36.17

-24.73

-2.79

12.79

5.19

NIOX Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															-0.13	10.96	1.95	3.66	1.52

Competitive Comparison of NIOX Group's Pre-Tax Income

For the Medical Devices subindustry, NIOX Group's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NIOX Group's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NIOX Group's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where NIOX Group's Pre-Tax Income falls into.

NIOX Group Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

NIOX Group's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	5.823	+	0	+	-0.127	+	1.013	+	-1.519
	=	5.19

NIOX Group's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	2.025	+	0	+	-0.126	+	0.506	+	-0.886
	=	1.52

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $5.18 Mil.

NIOX Group (OTCPK:CSSPF) Pre-Tax Income Explanation

NIOX Group's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	1.519	/	22.785
	=	6.67%

During the past 13 years, NIOX Group's highest Pretax Margin was 33.55%. The lowest was -581.48%. And the median was -79.77%.

NIOX Group Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of NIOX Group's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

NIOX Group (NIOX Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NIOX Group PLC (OTCPK:CSSPF) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

NIOX:UK 82C:Germany

Address

Edmund Halley Road, Hayakawa Building, The Oxford Science Park, Oxford, GBR, OX4 4GB

Website

https://investors.niox.com

NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.